The Optimal Adjuvant Strategy of Aidi Injection With Gemcitabine and Cisplatin in Advanced Non–small Cell Lung Cancer: A Meta-analysis of 70 Randomized Controlled Trials

Introduction: Aidi injection (Aidi) is composed of cantharidin, astragaloside, ginsenoside, and elentheroside E. As an important adjuvant therapy, Aidi in combination with gemcitabine and cisplatin (GP) is often used in the treatment of non-small cell lung cancer (NSCLC). Objectives: We performed a...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Pharmacol
Main Authors: Wang, Cheng-Qiong, Zheng, Xiao-Tian, Chen, Xiao-Fan, Jiang, Hong, Huang, Jun, Jiang, Yuan, Hu, Shan-Shan, Huang, Xiao-Rong, Liu, Shi-Yu, Gong, Qi-Hai, Feng, Ji-Hong, Xiao, Xue, Li, Xiao-Fei, Xiao, Zheng
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2021
Assuntos:
Pharmacology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8194277/
https://ncbi.nlm.nih.gov/pubmed/34122057
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2021.582447
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados